|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Zentalis Pharmaceuticals, Llc (ZNTL) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
84,924,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Co. is developing a pipeline of product candidates with an initial focus on validated oncology targets. Co. has two primary product candidates: ZN-c3, an inhibitor of Wee1, a protein tyrosine kinase, and ZN-c5, an oral selective estrogen receptor degrader. Co.'s other clinical product candidates include ZN-d5, a selective inhibitor of B-cell lymphoma 2 and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
22,000 |
22,000 |
Total Buy Value |
$0 |
$0 |
$219,391 |
$219,391 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
12,953 |
41,815 |
68,993 |
346,626 |
Total Sell Value |
$157,325 |
$490,017 |
$1,047,834 |
$8,137,870 |
Total People Sold |
2 |
5 |
8 |
8 |
Total Sell Transactions |
2 |
8 |
12 |
35 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gallagher Cam |
President |
|
2023-01-05 |
4 |
AS |
$21.01 |
$210,228 |
D/D |
(10,000) |
362,011 |
|
- |
|
Gallagher Cam |
President |
|
2022-11-15 |
4 |
AS |
$22.72 |
$284,683 |
D/D |
(12,500) |
372,011 |
|
- |
|
Bunker Kevin D. |
Chief Scientific Officer |
|
2022-11-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
784,110 |
|
- |
|
Gallagher Cam |
President |
|
2022-11-08 |
4 |
AS |
$23.56 |
$291,543 |
D/D |
(12,374) |
384,511 |
|
- |
|
Gallagher Cam |
President |
|
2022-11-07 |
4 |
AS |
$23.66 |
$295,860 |
D/D |
(12,500) |
396,885 |
|
- |
|
Gallagher Cam |
President |
|
2022-10-17 |
4 |
AS |
$23.51 |
$293,879 |
D/D |
(12,500) |
409,385 |
|
- |
|
Gallagher Cam |
President |
|
2022-10-06 |
4 |
AS |
$22.62 |
$226,180 |
D/D |
(10,000) |
421,885 |
|
- |
|
Gallagher Cam |
President |
|
2022-10-05 |
4 |
AS |
$21.92 |
$279,006 |
D/D |
(12,500) |
431,885 |
|
- |
|
Bunker Kevin D. |
Chief Scientific Officer |
|
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
814,110 |
|
- |
|
Brownstein Carrie |
Chief Medical Officer |
|
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
Epperly Melissa B, |
Chief Financial Officer |
|
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
297,543 |
|
- |
|
Gallagher Cam |
President |
|
2022-09-16 |
4 |
AS |
$24.38 |
$244,497 |
D/D |
(10,000) |
444,385 |
|
- |
|
Gallagher Cam |
President |
|
2022-09-15 |
4 |
AS |
$25.10 |
$315,757 |
D/D |
(12,500) |
454,385 |
|
- |
|
Skvarka Jan |
Director |
|
2022-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
36,606 |
36,606 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2022-08-10 |
4 |
AS |
$30.00 |
$150,000 |
I/I |
(5,000) |
95,000 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2022-07-20 |
4 |
AS |
$30.00 |
$150,000 |
I/I |
(5,000) |
100,000 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2022-07-14 |
4 |
AS |
$30.01 |
$98,721 |
I/I |
(3,290) |
105,000 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2022-07-13 |
4 |
AS |
$30.02 |
$51,341 |
I/I |
(1,710) |
108,290 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2022-07-05 |
4 |
AS |
$30.07 |
$751,653 |
I/I |
(25,000) |
110,000 |
|
- |
|
Kariuki Enoch |
Director |
|
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
21,817 |
21,817 |
|
- |
|
Johnson David Michael |
Director |
|
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
24,871 |
108,330 |
|
- |
|
Gallagher Cam |
President |
|
2022-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
111,072 |
466,885 |
|
- |
|
Goel David E. |
10% Owner |
|
2022-05-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,199,973 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2022-04-11 |
4 |
AS |
$30.37 |
$152,745 |
I/I |
(5,000) |
135,000 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2022-04-05 |
4 |
AS |
$51.34 |
$539,474 |
D/D |
(10,471) |
1,175,589 |
|
- |
|
243 Records found
|
|
Page 3 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|